Burkitt translocation (8;22)(q24;q11) in a patient with multiple myeloma.

[1]  G. I. Obrams,et al.  Epidemiology and Biology of Multiple Myeloma , 2012, Springer Berlin Heidelberg.

[2]  D. Vesole,et al.  Salvage therapy for multiple myeloma: the University of Arkansas experience. , 1994, Mayo Clinic proceedings.

[3]  M. Oken Standard treatment of multiple myeloma. , 1994, Mayo Clinic proceedings.

[4]  Francis J. Giles Multiple myeloma and other differentiated B-cell disorders. , 1994, Current opinion in hematology.

[5]  R. Chaganti,et al.  Hypermutation of the MYC gene in diffuse large cell lymphomas with translocations involving band 8q24 , 1993, Genes, chromosomes & cancer.

[6]  L. Meisner,et al.  Use of fluorescence in situ hybridization for retrospective detection of aneuploidy in multiple myeloma , 1993, Genes, chromosomes & cancer.

[7]  M. Boccadoro,et al.  Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma. , 1993, Bone marrow transplantation.

[8]  B. Durie Cellular and molecular genetic features of myeloma and related disorders. , 1992, Hematology/oncology clinics of North America.

[9]  R. Kyle,et al.  Diagnostic criteria of multiple myeloma. , 1992, Hematology/oncology clinics of North America.

[10]  W. Carroll,et al.  c-myc hypermutation is ongoing in endemic, but not all Burkitt's lymphoma. , 1991, Blood.

[11]  B. Klein,et al.  Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. , 1989, Blood.

[12]  I. Lisse,et al.  Occurrence and type of chromosomal abnormalities in consecutive malignant monoclonal gammopathies: correlation with survival. , 1988, Cancer genetics and cytogenetics.

[13]  E. Newcomb,et al.  Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts , 1987, Cell.

[14]  R. Kyle,et al.  The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. , 1985, Blood.

[15]  S. Raptis,et al.  Cytogenetic study in multiple myeloma. , 1984, Cancer genetics and cytogenetics.

[16]  R. R. Howe,et al.  Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. , 1982, The New England journal of medicine.

[17]  N. E. Hansen,et al.  Chromosomes and survival in multiple myeloma. A banding study of 25 cases , 1980 .

[18]  D. Hossfeld,et al.  Karyotype in multiple myeloma and plasma cell leukaemia. , 1993, European journal of cancer.

[19]  D. Ledbetter,et al.  Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. , 1988, Blood.

[20]  M. Cole The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.